Hepatocyte growth factor demonstrates racial heterogeneity as a biomarker for coronary heart disease. - Wikidata - awgldk - TriplyDB

Hepatocyte growth factor demonstrates racial heterogeneity as a biomarker for coronary heart disease.

Hepatocyte growth factor demonstrates racial heterogeneity as a biomarker for coronary heart disease.

http://www.wikidata.org/entity/Q30252228

about

Hepatocyte growth factor is associated with progression of atherosclerosis: The Multi-Ethnic Study of Atherosclerosis (MESA).

P2860

Q52612811-D9C222A5-EBA6-47E4-9A6C-71AB2731EC56

P2860

Hepatocyte growth factor demonstrates racial heterogeneity as a biomarker for coronary heart disease.

http://www.wikidata.org/entity/Q30252228

description

2017 nî lūn-bûn

@nan

2017 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2017 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

name

Hepatocyte growth factor demon ...... er for coronary heart disease.

@ast

Hepatocyte growth factor demon ...... er for coronary heart disease.

@en

type

label

Hepatocyte growth factor demon ...... er for coronary heart disease.

@ast

Hepatocyte growth factor demon ...... er for coronary heart disease.

@en

altLabel

Hepatocyte growth factor demon ...... ker for coronary heart disease

@en

prefLabel

Hepatocyte growth factor demon ...... er for coronary heart disease.

@ast

Hepatocyte growth factor demon ...... er for coronary heart disease.

@en

P1433

Q30252228-3976350C-29BD-4B20-B4BC-997F3DF131AD

P1476

Q30252228-92AD7558-B3AB-4678-8CB7-BDA99197DC1E

P2093

Q30252228-1C812DB5-4712-4E44-956F-875B7ED5D7CF

Q30252228-5C31F52A-43AC-4529-B253-B6675229592B

Q30252228-66A23AA4-395E-499D-A94A-B82A1FB0604C

Q30252228-73A03912-7894-4784-9697-5606F002EAFA

Q30252228-93A7C45B-80A3-4C52-9E02-0877AA386807

Q30252228-9F21D00D-B56A-4A90-AA29-E4C8D74344E9

Q30252228-A07D1561-A493-4C97-9173-BB5D0B40AF69

Q30252228-AC48C565-E4F8-4BB5-ADAB-EF714F29A8BD

Q30252228-B324F87F-418D-4C2A-9D56-E99910267E3D

Q30252228-C478B96D-7B33-457E-B3EA-294BC8D4ADE4

P2860

Q30252228-12F3D4A8-DD6D-4DBC-956F-63744C3B3A98

Q30252228-163267DA-561E-4ECE-A34B-939C996F8A7E

Q30252228-1EF04F4D-8374-4224-B09B-2886735E9F41

Q30252228-24948660-D6C4-47AD-9654-60ABE455FD43

Q30252228-3B4E633A-2682-4B8F-A5C8-EB48393F2E46

Q30252228-524DCF8B-3376-497D-AF99-FCD0D0725A85

Q30252228-5E41F1BB-A788-4F1B-ABAA-9E47373E87A0

Q30252228-7303DB84-49D2-4C26-961B-05D54A28FC1C

Q30252228-820DCF04-8069-4255-BFCF-CAD54591CC6B

Q30252228-A5806E5F-14E4-406E-BAAC-D3C414F3FD02

P304

Q30252228-83393AA3-78B6-4E6F-A359-BE2E0579AD11

P31

Q30252228-A9AA2916-DE7F-496C-B529-70F706A14D9D

P356

Q30252228-3AC57CE0-5EA5-4865-A9A5-1760BA721FE3

P407

Q30252228-8A037450-5AF9-4E6E-9658-EAD36BC97E1C

P433

Q30252228-E2921AC6-2185-4C80-8A77-7F8370836DCF

P478

Q30252228-2A6E232A-81F3-45CD-832F-B10961911FCD

P50

Q30252228-981638ED-685D-464D-ABE8-79A35644A498

Q30252228-B6CE81D5-43B6-4166-A059-73B4B08A2323

Q30252228-BBFCFCA7-7BFA-4309-8F00-16714E9CCAB8

P577

Q30252228-AEAACD15-AEDE-4372-876A-9DC407CBE2AA

P698

Q30252228-D35D2CFA-2D4B-488B-B1E9-656ECDC6838F

P921

Q30252228-EB8C5EB0-7B91-43DE-85AD-429CE38AAE31

P932

Q30252228-00FC27B6-30A7-4026-AE93-A47C28D1E4C4

P356

HEARTJNL-2016-310450

P1433

P1476

Hepatocyte growth factor demon ...... er for coronary heart disease.

@en

P2093

Cecilia Berardi

http://www.w3.org/2001/XMLSchema#string

Christina L Wassel

http://www.w3.org/2001/XMLSchema#string

Elizabeth J Bell

http://www.w3.org/2001/XMLSchema#string

Hugues Sicotte

http://www.w3.org/2001/XMLSchema#string

Joseph F Polak

http://www.w3.org/2001/XMLSchema#string

Mariza de Andrade

http://www.w3.org/2001/XMLSchema#string

Michele M Sale

http://www.w3.org/2001/XMLSchema#string

Naomi Q Hanson

http://www.w3.org/2001/XMLSchema#string

Nicholas B Larson

http://www.w3.org/2001/XMLSchema#string

Paul A Decker

http://www.w3.org/2001/XMLSchema#string

P2860

Agonist antibodies activating the Met receptor protect cardiomyoblasts from cobalt chloride-induced apoptosis and autophagy

Trans-ethnic meta-analysis identifies common and rare variants associated with hepatocyte growth factor levels in the Multi-Ethnic Study of Atherosclerosis (MESA).

Comparison of coronary artery calcium presence, carotid plaque presence, and carotid intima-media thickness for cardiovascular disease prediction in the Multi-Ethnic Study of Atherosclerosis.

Hepatocyte growth factor is a strong predictor of mortality in patients with advanced heart failure

Multi-Ethnic Study of Atherosclerosis: objectives and design

Hepatocyte growth factor and clinical diabetes in postmenopausal women.

Associations of common carotid intima-media thickness with coronary heart disease risk factors and events vary with distance from the carotid bulb.

Calcified coronary artery plaque measurement with cardiac CT in population-based studies: standardized protocol of Multi-Ethnic Study of Atherosclerosis (MESA) and Coronary Artery Risk Development in Young Adults (CARDIA) study.

Scatter factor induces blood vessel formation in vivo.

Circulating level of hepatocyte growth factor predicts incidence of type 2 diabetes mellitus: The Multi-Ethnic Study of Atherosclerosis (MESA).

P304

1185-1193

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/HEARTJNL-2016-310450

http://www.w3.org/2001/XMLSchema#string

P407

P433

15

http://www.w3.org/2001/XMLSchema#string

P478

103

http://www.w3.org/2001/XMLSchema#string

P50

James S. Pankow

Michael Y. Tsai

Matthew J Budoff

P577

2017-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28572400

http://www.w3.org/2001/XMLSchema#string

P921

P932

5511548

http://www.w3.org/2001/XMLSchema#string